Terodiline
Clinical data | |
---|---|
ATC code | G04BD05 (WHO) |
Identifiers | |
| |
PubChem (CID) | 23480 |
ChemSpider | 21952 |
UNII | 70KG06964W |
ChEMBL | CHEMBL363295 |
Chemical and physical data | |
Formula | C20H27N |
Molar mass | 281.435 g/mol |
3D model (Jmol) | Interactive image |
| |
| |
(verify) |
Terodiline is a drug used in urology as an antispasmodic.
It relaxes the smooth muscle and used to reduce bladder tone in treatment of urinary frequency and incontinence. Muscle relaxation caused by terodiline, is probably due to its anticholinergic and calcium antagonist activity.
However, it also blocks IKr (Kv11.1) channels (see hERG gene) so can pose a risk for torsades de pointes. This cardiotoxicity is concentration dependent.[1]
References
- ↑ Thomas SH, Higham PD, Hartigan-Go K, Kamali F, Wood P, Campbell RW, Ford GA. "Concentration dependent cardiotoxicity of terodiline in patients treated for urinary incontinence".
This article is issued from Wikipedia - version of the 6/6/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.